drugset / Trial / NCT01666730

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

NCT01666730 ↗

Phase 2 Completed 50 enrolled Case Comprehensive Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well metformin hydrochloride, leucovorin calcium, fluorouracil, and oxaliplatin work in treating patients with metastatic pancreatic cancer. Metformin hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as leucovorin calcium, fluorouracil, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving metformin hydrochloride together with combination chemotherapy may kill more tumor cells

Timeline

Start
2013-02-21
Primary completion
2018-08-01
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — Oral
Background Leucovorin Small molecule — Intravenous
Background Oxaliplatin Small molecule — Intravenous
Background fluorouracil Small molecule — Intravenous